A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer.

MLA

Qvortrup, C., et al. “A Randomized Study Comparing Short-Time Infusion of Oxaliplatin in Combination with Capecitabine XELOX(30) and Chronomodulated XELOX(30) as First-Line Therapy in Patients with Advanced Colorectal Cancer.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 21, no. 1, Jan. 2010, pp. 87–91. EBSCOhost, https://doi.org/10.1093/annonc/mdp272.

APA

Qvortrup, C., Jensen, B. V., Fokstuen, T., Nielsen, S. E., Keldsen, N., Glimelius, B., Bjerregaard, B., Mejer, J., Larsen, F. O., & Pfeiffer, P. (2010). A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 21(1), 87–91. https://doi.org/10.1093/annonc/mdp272

Chicago

Qvortrup, C, B V Jensen, T Fokstuen, S E Nielsen, N Keldsen, B Glimelius, B Bjerregaard, J Mejer, F O Larsen, and P Pfeiffer. 2010. “A Randomized Study Comparing Short-Time Infusion of Oxaliplatin in Combination with Capecitabine XELOX(30) and Chronomodulated XELOX(30) as First-Line Therapy in Patients with Advanced Colorectal Cancer.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 21 (1): 87–91. doi:10.1093/annonc/mdp272.